http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Hyundai Expands its Commitment to STEM Education Across the United States
-
MNA: DPH Presses MGB for Answers on Burn Unit Closure Plan, Echoing Nurses' Concerns About Safety and Capacity at Brigham and Women's Hospital
-
Eguana and ITOCHU Amend Unsecured Convertible Debenture Maturity Date to April 30th
-
True Tickets Expands Across Leading Ballet Companies as Institutions Modernize Ticketing and Audience Engagement
-
True Tickets Expands Across Leading Ballet Companies as Institutions Modernize Ticketing and Audience Engagement
-
Check Point Launches AI Defense Plane to Secure the Agentic Enterprise at Scale
-
CSX Corp. Announces Date for First Quarter Earnings Release and Earnings Call
-
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
-
Enterprises Rush into GenAI Without Security Foundations, New Ponemon Study Finds
-
Check Point Releases AI Factory Security Blueprint to Safeguard AI Infrastructure from GPU Servers to LLM Prompts
-
WILLIAMS SONOMA UNVEILS NEWLY RENOVATED TEST KITCHEN
-
CSX Corp. Announces Date for First Quarter Earnings Release and Earnings Call
-
Arctic Wolf and Wiz Join Forces to Counter Rising Cloud Threats with End‑to‑End Cloud Security and Response
-
Versa Simplifies Secure Branch Connectivity with Automated Integration for Zscaler Internet Access
-
Coro Expands AI-Driven Security Operations, Automates 92% of Alerts
-
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
-
Angkor Resources Announces Further Field Research for Cambodia's Oil and Gas With Mentorship for ITC Graduate Geoscientists
-
Fransmart Appoints Sara Schmillen as Chief Marketing Officer
-
Blackstone Names Courtney Reagan Senior Editor of Blackstone Insights
-
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
-
Meet the New Zenbook DUO (2026): More Power, More Screens, More Innovation, Pre-Orders Now Open
-
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
-
Rubrik integrates with Microsoft Defender for identity attack response
-
New Microsoft and Rubrik Integration Delivers Complete Identity Attack Response
-
Rubrik launches AI governance engine for autonomous agents
-
OneSpan Named an Overall Leader in KuppingerCole Analyst’s Leadership Compass for Passwordless Authentication
-
On National Viagra Day, Women Finally Claim Their Turn:
-
Rubrik Rolls Out Industry’s First Semantic AI Governance Engine
-
RUMPLE MINZE ADDS A NEW CHAPTER TO ITS LORE WITH THE LAUNCH OF RUMPLE MINZE CINNAMINT WHISKEY
-
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026
-
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026
-
Immunexpress Presenting at the Society of Critical Care Medicine (SCCM) 2026 Critical Care Congress Showing SeptiCyte RAPID® High Correlation with Blood Culture Positive Sepsis Patients
-
Sue Ennis Joins Realbotix to Lead Direct-to-Consumer Business
-
Kobo Resources plans $5.5 million private placement for gold projects
-
Kobo Resources Announces Non-Brokered Private Placement of up to $5.5 Million to Advance Kossou and Regional Growth
-
Palvella hires Jennifer McDonough as market access VP
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
Ford and Major League Baseball Unite to Celebrate America’s Pastime and the People Who Power It
-
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservat
-
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
ClearCompany Rebrands as ClearCo, Signaling Its Evolution into an AI- and Agent-Powered Unified Talent Platform
-
Core Scientific secures additional $500 million from J.P. Morgan
-
FDA grants priority review to Ionis' Alexander disease treatment
-
Q2 Metals Announces Multiple 200+ Metre Intervals of Continuous Spodumene Pegmatite and Provides an Update on the Inaugural Mineral Resource Estimate at the Cisco Lithium Project, Quebec, Canada
-
Core Scientific Expands Strategic Financing Facility to $1 Billion with Additional $500 Million Commitment from J.P. Morgan
-
Cunard Announces Exclusive Partnership with Celebrity Fashion Stylist Micaela Erlanger
-
West Point Gold Expands the Ongoing Fully Funded Drill Program to 20,000m
-
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
-
Victory Capital defends Janus Henderson acquisition proposal
